Taking your project from bench to clinical studies

OUR SERVICES
 

GMP facilities for injectable and freeze-dried biological products

OUR SERVICES
 

Manufacture of small customized clinical batches

KNOW MORE
 

Biosafety level 3 (BSL-3) facility under GMP

MORE INFORMATION
 

Our own project to develop a vaccine against tuberculosis

RUTI® Project
1
1

Archivel Farma is a biotech company focused on innovative immunotherapeutic products.

Archivel Farma is specialized in the development of injectable and freeze-dried products.

Manufacturing

Process Development & Tech Transfer Scale-up & GMPs manufacturing

Facilities

Biosafety level 3 (BSL-3)
Class A/B cleanroom

Analytical QC & RD

Development, validation and testing analytical methods

Qualified Team

Personal trained
CXPs and biosafety standards

News

Archivel-Farma-Joint-Efforts-in-Tuberculosis-Research Archivel
20/10/2025

RUTI® in combination with BCG Therapy Show Encouraging Outcomes in Bladder Cancer

Archivel Farma is delighted to anounce the outcome of RUTIVAC study in Bladder Cancer. The RUTI® vaccine, developed and produced in-house by Archivel Farma, was tested in a phase I…
Albert Canals
0
Archivel-Farma-Joint-Efforts-in-Tuberculosis-Research Archivel
02/08/2025

Joint Efforts in Tuberculosis Research: TB Alliance Visits Archivel

We were pleased to welcome Natalya Serbina, Senior Director at TB Alliance, to Archivel as part of our ongoing collaboration within the international Host Directed Therapy in Tuberculosis project. This…
Albert Canals
0
Archivel Farma TBL Day 2025 ArchivelGeneral
23/03/2025

Tuberculosis Is A Global Emergency

“Yes! We Can End TB: Commit, Invest, Deliver” TB continues to cause immense human suffering and severe health, social, and economic consequences across the world. Every year, 10 million people…
Albert Canals
0